Top Losers

DreamWorks Animation SKG (NASDAQ: DWA) shares dropped 13.64% to $22.47 in pre-market trading. Talks between Hasbro (NASDAQ: HAS) and DreamWorks Animation have apparently stalled and are unlikely to resume, according to sources reported by WSJ. Inovio Pharmaceuticals (NASDAQ: INO) shares slipped 12...

Abengoa SA (NASDAQ: ABGB) shares slipped 43.52% to $8.50 following the drop in value of company's bonds on cautious conference call comments. Charles & Colvard (NASDAQ: CTHR) shares dipped 35.50% to $1.69 after the company reported a Q3 net loss of $3.1 million on sales of $4.5 million. Movado...

Abengoa SA (NASDAQ: ABGB) shares dropped 50.30% to $7.48 in pre-market trading after falling 10.42% on Thursday. CSX (NYSE: CSX) shares slipped 7.70% to $33.81 in pre-market trading after falling 0.38% on Thursday. SINA (NASDAQ: SINA) fell 4.47% to $39.98 in pre-market trading after the China...

Revance Therapeutics (NASDAQ: RVNC) shares dipped 28.33% to $15.05 after the company reported a Q3 net loss of $14.0 million, versus a year-ago loss of $8.9 million. Local (NASDAQ: LOCM) shares fell 24.63% to $1.30 after the company reported a Q3 loss of $0.06 per share on revenue of $18.10 million...

J. C. Penney Company (NYSE: JCP) shares dropped 7.35% to $7.19 in pre-market trading after the company reported a narrower-than-expected third-quarter loss, but its sales were slightly below the Wall Street consensus. The company also posted flat same-store sales in the quarter. Regulus...

Kamada (NASDAQ: KMDA) shares tumbled 14.47% to $3.25 after the company reported a Q3 net loss of $0.09 per share on revenue of $17.2 million. Plug Power (NASDAQ: PLUG) dropped 14.07% to $4.37 after the company posted a wider-than-expected third-quarter loss. Altisource Portfolio Solutions S.A. (...

Kamada (NASDAQ: KMDA) shares slipped 15.79% to $3.20 in pre-market trading after the company reported a Q3 net loss of $0.09 per share on revenue of $17.2 million. Plug Power (NASDAQ: PLUG) fell 13.19% to $4.41 in pre-market trading after the company posted a wider-than-expected third-quarter loss...

Turtle Beach (NASDAQ: HEAR) shares fell 28.65% to $3.71 on Q3 results. The company posted a quarterly net loss of $5.6 million, or $0.13 per diluted share, versus a year-ago net loss of $1.4 million, or $0.11 per diluted share. Applied Optoelectronics (NASDAQ: AAOI) shares declined 24.11% to $11.90...

Vivint Solar (NYSE: VSLR) shares slipped 12.48% to $12.90 in pre-market trading after the company reported a wider-than-expected quarterly loss. Mid-Con Energy Partners, LP (NASDAQ: MCEP) fell 6.39% to $16.84 in pre-market trading after the company announced a public offering of 5.8 million common...

Dendreon (NASDAQ: DNDN) shares dipped 65.71% to $0.32 on Chapter 11 filing. Rayonier (NYSE: RYN) shares dropped 13.50% to $29.32. Rayonier reported better-than-expected earnings for the third quarter. The company announced its plans to realign its strategy. It also restated results for the first...

Dendreon (NASDAQ: DNDN) shares slipped 67.09% to $0.31 in pre-market trading on Chapter 11 filing. Gogo (NASDAQ: GOGO) fell 9.80% to $15.01 in pre-market trading after the company reported a wider-than-expected Q3 loss. GoPro (NASDAQ: GPRO) shares dropped 5.51% to $74.70 in pre-market trading after...

Roka Bioscience (NASDAQ: ROKA) dipped 39.93% to $5.01 after the company reported Q3 results. Bank of America downgraded Roka Bioscience from Buy to Neutral. Salix Pharmaceuticals (NASDAQ: SLXP) shares tumbled 36.12% to $88.50 after the company reported downbeat Q3 results and appointed Timothy...

Salix Pharmaceuticals (NASDAQ: SLXP) shares slipped 33.79% to $91.74 in pre-market trading after the company reported downbeat Q3 results and appointed Timothy Creech as CFO. Analysts at Stifel Nicolaus downgraded Salix Pharma from Buy to Hold and removed the price target of $189. Performant...

Aeterna Zentaris (NASDAQ: AEZS) shares dipped 48.06% to $0.67 after the company announced that it has received a complete response letter from the FDA for Macrilen. Solazyme (NASDAQ: SZYM) shares dropped 48.01% to $3.89 after the company reported a Q3 loss of $0.45 per share on revenue of $17.60...

Solazyme (NASDAQ: SZYM) shares slipped 37.52% to $4.68 in pre-market trading after the company reported a Q3 loss of $0.45 per share on revenue of $17.60 million and launched a partnership with Versalis to commercialize Encapso. Cowen & Company downgraded Solazyme from Outperform to Market...